• Programme 2025
• Programme 2024
• Programme 2023
• Programme 2022
• Programme 2020
• CME 2020
• Programme 2019
• Programme 2018
• CME 2018
• Programme 2017
• CME 2017
• Programme 2016

Programme 2024

Wednesday 17th January 2024
SESSION: EVOLVING DONOR PRESERVATION TECHNIQUES
Moderator: Michiel Erasmus + one young investigator
	(20 min talk and 10 min Q&A)
16.00–16.30	DBD heart trial XVIVO,	Filip Rega Leuven, Belgium
16.30–17.00	EVLP on DCD lungs	Eduoard Sage Suresnes, France
17.00–17.30	European data on SherpaPak	Andreas Zuckermann Vienna, Austria
17.30–18.00	Coffee Break
Session - Fascinating Failures and Surprising Successes
Moderator: Katrijn Jansen + one young investigator
	(10 min talk and 5 min Q&A)
	18.00–18.15 How to mess up CMV prophylaxis	Erik Verschuuren Groningen, The Netherlands
	18.15–18.30 Isolated heart transplant in child with CHD related PH	Mohamed Nassar Newcastle upon Tyne, UK
	18.30–18.45 The dratted fungus in a heart-lung transplant recipient	Dr Anja Roden Rochester Minnesota, USA
	18.45–19.00 From Heaven to Hell – primary cardiac intimal sarcoma	Ivan Knezevic Ljubljana, Slovenia
	19.00–19.15 Fatal Airway complication after Lung transplantation	Arve Sundset Oslo, Norway
	19.15–19.30 A big hole in a small patient: Iatrogenic esophageal perforation after bilateral lobar lung transplantation	Martin Silverborn Gothenburg, Sweden
Thursday 18th January 2024
SESSION: NEW WAYS OF MONITORING GRAFT FUNCTION
Moderator: Göran Dellgren + young investigator
	(15 min talk and 5 min Q&A)
16.00–16.20	Airway oscillometry parameters in baseline lung allograft dysfunction – multicentre study	Greg Snell, Melbourne, Australia
16.20–16.40	Cell-free DNA as biomarker after heart and lung transplantation	Jens Böhmer, Gothenburg, Sweden
16.40–17.00	Multiomics signatures that precede CLAD in lung transplantation	Greg Westall, Melbourne, Australia
17.00–17.15	Business Meeting
17.15–17.30	Coffee break
SESSION: MECHANICAL CIRCULATORY SUPPORT FROM CHILD TO ADULT
Clive Lewis and young investigator
	(15 min talk and 5 min Q&A)
17.30–17.50	ECMO and alternatives as bridge to transplant in the paediatric population	Judit Llevadias, Newcastle upon Tyne, UK
17.50–18.10	Short term mechanical circulatory support in adults – whats the current practice	Hassiba Smail, Cambridge, UK
18.10–18.30	Introduction of EXCOR Revive and the EXCOR venous cannula in the failing Fontan	Joeri van Puyvelde Leuven, Belgium
18.30–18.50	Present State and Upcoming Developments of LVAD Therapy	Stephan Schueler, Newcastle upon Tyne, UK
18.50–19.00	Coffee break
19.00–19.30	Session: WERNER ZUBER MEMORIAL LECTURE
	19.00–19.30 Deepsea Diving	Jan Risberg, Bergen, Norway
Friday 19st January 2024
SESSION: CURRENT AND FUTURE CHALLENGES IN PULMONARY HYPERTENSION AND TRANSPLANTATION
Michael Perch + young investigator
	(20 min talk and 10 min Q&A)
16.00–16.30	Differentiation of unclear dyspnea and pulmonary hypertension – who to treat and not to treat?	Göran Radegran, Lund, Sweden
16.30–17.00	Desensitization in heart and lung transplantation- where do we stand today?	John Scott, Rochester Minnesota, USA
17.00–17.30	Park and preserve of donor lungs	Niels van der Kaaij Utrecht, The Netherlands
17.30–17.45	Coffee break
17.45–18.15
Moderator: Hans Eiskjaer
PRO-CON DEBATE Heart and lungs from COVID positive donor - To use or not to use?	Pro: Erik Verschuuren, Groningen, The Netherlands Con: Margaret Hannan, Dublin, Ireland
18.15–18.30	Coffee break
18.30–19.30	Session: Young Investigators Award (8 min. talk and 2 min Q&A)
	18.30–18.40 Pregnancy after lung transplantation in the Netherlands	Jildau Meinderts Groningen, The Netherlands
	18.40–18.50 Immunogenic changes after peri-transplant desensitization in patients with preformed donor specific antibodies in lung transplantation: a ten-year single centre experience	Philipp Wand Hannover, Germany
	18.50–19.00 Paediatric lung transplantation in the Netherlands: a 27-year single centre experience	Anton Van As Groningen, The Netherlands
	19.00–19.10 Targeting sphingosine-1-phosphate receptor-1 protects vascular endothelial integrity during human ex vivo lung perfusion	Jenny Gilmour Newcastle upon Tyne, UK
	19.10–19.20 Microdialysis used to measure myocardial ischemic metabolites in both cardiac ventricles in the DCD donor during NRP followed by static cold storage and subsequent heart transplantation.	Maja Thomassen Aarhus, Denmark
	19.20–19.30 Preserving mitochondrial function in donor heart preservation with sodium thiosulfate: a pre-clinical ovine model.	Imran Ertugrul Groningen, The Netherlands